1.
Diaz-Buxo JA, Suki WN: Automated peritoneal dialysis; in Gokal R, Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer, 1994, pp 399–418.
2.
Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK: Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978;88:449–456.
3.
Diaz-Buxo JA, Farmer CD, Walker PJ, Chandler JT, Holt KL: Continuous cyclic peritoneal dialysis: A preliminary report. Artif Organs 1981;5:157–161.
4.
Price CG, Suki WN: Newer modifications of peritoneal dialysis: Options in the treatment of patients with renal failure. Am J Nephrol 1981;1:97–104.
5.
McComb J, Morton AR, Singer MA, Hopman WM, MacKenzie T: Impact of portable APD on patient perception of health-related quality of life. Adv Perit Dial 1997;13:137–140.
6.
US Renal Data System, CD ROM version 1997.
7.
Diaz-Buxo JA, Gotch FA, Folden T, Rosenblum S, Zazra J, Lew NL, Crawford T, Youngblood B, Pesich A, Lazarus JM: Peritoneal dialysis adequacy: A model to assess feasibility with various modalities. Kidney Int 1999;55:2493–2501.
8.
NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation. Am J Kidney Dis 1997;30(suppl 2):S80–S92.
9.
Diaz-Buxo JA, Youngblood BP, Torres AM: Delivered dialysis dose with PD Plus therapy: A multicenter study. Am J Nephrol 1998;18:520–524.
10.
Twardowski ZJ: Peritoneal dialysis glossary II. Perit Dial Int 1988;8:15–17.
11.
Durand PY, Slingeneyer A, Benevent D, Chanliau J: CAPD: Peritoneal clearances with a 5th nocturnal automated exchange (Baxter Quantum) (abstract). Perit Dial Int 1997;17(suppl 1):S15.
12.
Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, Hull AR, Korbet SM, Moran J, Nolph KD: Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996;16:448–456.
13.
Keshaviah P, Emerson PF, Vonesh EF, Brandes JC: Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 1994;4:1820–1826.
14.
Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M: APD: Clinical measurement of the maximal acceptable intraperitoneal volume. Adv Perit Dial 1994;10:63–67.
15.
Twardowski ZJ, Nolph KD, Khanna R, et al: Peritoneal equilibration test. Perit Dial Bull 1987;7:138–147.
16.
Twardowski ZJ: Clinical value of standardised tests in CAPD patients. Blood Purif 1989;7:95–108.
17.
Durand PY, Freida P, Issad B, Chanliau J: How to reach optimal creatinine clearance in automated peritoneal dialysis. Perit Dial Int 1996;16(suppl 1):S167–S170.
18.
Twardowski ZJ: Nightly peritoneal dialysis. Why, who, how and when. ASAIO Trans 1990;36:8–16.
19.
Amici G, Virga G, Da Rin G, Bocci C, Calconi G: Continuous tidal peritoneal dialysis (CTPD) prescription and adequacy targets. Adv Perit Dial 1998;14:64–67.
20.
Holley JL, Piraino B: Careful patient selection and dialysis prescription are required for effective nightly intermittent peritoneal dialysis. Perit Dial Int 1994;14:155–158.
21.
Friedlander MA, Rahman M, Tessman MJ, Hanslik TM, Ferrara KA, Newman LN: Variability in calculations of dialysis adequacy in patients using nightly intermittent peritoneal dialysis compared to CAPD. Adv Perit Dial 1995;11:93–96.
22.
Ronco C, Bosch JP, Lew SQ, et al: Adequacy of continuous ambulatory peritoneal dialysis: Comparison with other dialysis techniques. Kidney Int 1994;46(suppl 48):S18–S24.
23.
Piraino B, Bender F, Bernardini J: A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis. Perit Dial Int 1994;14:145–148.
24.
Steinhauer HB, Keck I, Lubrich-Birkner I, Schollmeyer P: Increased dialysis efficiency in tidal peritoneal dialysis compared to intermittent peritoneal dialysis. Nephron 1991;58:500–501.
25.
Flanigan MJ, Doyle C, Lim VS, Ullrich G: Tidal peritoneal dialysis: Preliminary experience. Perit Dial Int 1992;12:304–308.
26.
Brandes JC, Packard WJ, Watters SK, Fritsche C: Optimization of dialysate flow and mass transfer during automated peritoneal dialysis. Am J Kidney Dis 1995;25:603–610.
27.
Frank HA, Seligman AM, Fine J: Further experiences with peritoneal irrigation for acute renal failure. Ann Surg 1948;128:561–608.
28.
Rosenak SS, Oppenheimer GD: An improved drain for peritoneal lavage. Surgery 1948;23:832–833.
29.
Wear JB, Sisk IR, Trinkle AJ: Peritoneal lavage in the treatment of uremia. J Urol 1938;39:53–62.
30.
Diaz-Buxo JA: Renal care 2000 – Peritoneal dialysis. Nephrol News Issues 1999;13:12–16.
31.
Diaz-Buxo JA: Continuous cycling peritoneal dialysis, PD plus, and high-flow automated peritoneal dialysis: A spectrum of therapies. Perit Dial Int 2000;20:S93–S97.
32.
Diaz-Buxo JA: Continuous ambulatory and continuous cycling peritoneal dialysis; in LaGreca G, Chiaramonte S, Fabris A, Feriani M, Ronco C (eds): Peritoneal Dialysis. Milan, Wichtig Editore, 1986, pp 257–264.
33.
Vlaanderen K, de Fijter CW, Bos HJ, van der Meulen J, Beelen RH, Oe PL, Verbrugh HA: The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients. Adv Perit Dial 1989;5:151–153.
34.
de Fijter CWH, Verbrugh HA, Oe PL, Peters EDJ, van der Meulen J, Donker AJM, Verhoef J: Peritoneal defenses in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992;42:947–950.
35.
Wrenger E, Baumann C, Behrend M, Zamore E, Schindler R, Brunkhorst R: Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis. Am J Kidney Dis 1998;31:234–241.
36.
Cruz C, Melendez A, Gotch F, Folden T, Levin NW, Crawford T, Diaz-Buxo JA: Continuous flow peritoneal dialysis (CFPD): Preliminary clinical experience. Perit Dial Int 2000;20(suppl 1):S6.
37.
Raj DSC, Self M, Work J: Hybrid dialysis: Recirculation peritoneal dialysis revisited. Am J Kidney Dis 2000;36:58–67.
38.
Mineshima M, Suzuki S, Sato Y, Ishimori I, Ishida K, Kaneko I, Agishi T: Solute removal characteristics of continuous recirculating peritoneal dialysis in experimental and clinical studies. ASAIO J 2000;46:95–98.
39.
Twardowski ZJ, Prowant BF, Nolph KD, Martinez AJ, Lampton LM: High volume, low frequency continuos ambulatory peritoneal dialysis. Kidney Int 1983;23:64–70.
40.
Freida PH, Issad B, Allouache M: Relationships between fill volume, small solute clearances, and net ultrafiltration during a standardized APD program (abstract). Perit Dial Int 1998;18:124.
41.
Computer-Assisted Kinetic Modeling Approach to Achieving Target Doses of Peritoneal Dialysis: NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation. Am J Kidney Dis 1997;30(suppl 2):S90–S92.
42.
Vonesh EF, Lysaght MJ, Moran J, Farrell P: Kinetic modeling as a prescription aid in peritoneal dialysis. Blood Purif 1991;9:246–270.
43.
Vonesh EF, Burkart J, McMurray SD, Williams PF: Peritoneal dialysis kinetic modeling: Validation in a multicenter clinical study. Perit Dial Int 1996;16:471–481.
44.
Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991;40:315–325.
45.
Haraldsson B: Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 1995;47:1187–1198.
46.
Gotch FA, Keen ML: Kinetic modeling in peritoneal dialysis; in Nissenson AR, Fine RN, Gentile DE (eds): Clinical Dialysis, ed 3. Norwalk, Appleton & Lange, 1996, pp 343–375.
47.
Gotch FA, Lipps BJ, Keen ML, Panlilio F: Computerized urea kinetic modeling to prescribe and monitor delivered Kt/V (pKt/V, dKt/V) in peritoneal dialysis. Adv Perit Dial 1996;12:43–45.
48.
Amici G, Mastrosimone S, Da Rin G, Bocci C, Bonadonna A: Clinical validation of PD Adequest software: Modeling error assessment. Perit Dial Int 1998;18:317–321.
49.
Verrina E, Amici G, Perfumo F, Trivelli A, Canepa A, Gusmano R: The use of the PD Adequest mathematical model in pediatric patients on chronic peritoneal dialysis. Perit Dial Int 1998;18:322–328.
50.
Struijk DG, Douma CE: Future research in peritoneal dialysis fluids. Semin Dial 1998;11:207–212.
51.
Ash SR, Janle EM: Continuous flow-through peritoneal dialysis (CFPD): Comparison of efficiency to IPD, TPD, and CAPD in an animal model. Perit Dial Int 1997;17:365–372.
52.
Ronco C, Brendolan A, Zanella M: Evolution of machines for automated peritoneal dialysis; in Ronco C, Amici G, Feriani M, Virga G (eds): Automated Peritoneal Dialysis. Contrib Nephrol. Basel, Karger, 1999, vol 129, pp 142–161.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.